Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Antibody Titles After Meningococcal Vaccination in Patients With Myasthenia Gravis and Neuromyelitis Optica Candidate to Complement Inhibitors Therapy

NCT06906692 is registered in ClinicalTrials.gov with Fondazione Policlinico Universitario Agostino Gemelli IRCCS as lead sponsor.

NCT NCT06906692
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06906692 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Antibody Titles After Meningococcal Vaccination in Patients With Myasthenia Gravis and Neuromyelitis Optica Candidate to Complement Inhibitors Therapy
Lead sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase
Observational
Overall status
Active, not recruiting
Start date
March 25, 2025
Completion date
April 1, 2027
Enrollment
35 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

complement system, myasthenia gravis generalised, neuromyelitis optica spectrum disease (nmosd), vaccination